NCT04776694|Unknown
Compassionate Use of Dupilumab
1 other identifier
R668-Dupilumab
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredMar 2021
Brief Summary
Provide Compassionate Use of Dupilumab
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2021
Completed5 days until next milestone
First Posted
Study publicly available on registry
March 2, 2021
CompletedLast Updated
September 22, 2025
Status Verified
September 1, 2025
First QC Date
February 25, 2021
Last Update Submit
September 17, 2025
Conditions
Interventions
DupilumabDRUG
Also known as: REGN668, DUPIXENT®, SAR231893
Sponsors & Collaborators
MeSH Terms
Interventions
dupilumab
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2021
First Posted
March 2, 2021
Last Updated
September 22, 2025
Record last verified: 2025-09